| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.21 | 8e-05 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.18 | 0.0004 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.86 | 0.0004 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.0005 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |